Field Notes #3: Washington’s Busy Week, and the Biggest Psychedelic Buyout Yet By Watertime - July 17, 2026 4 Post Content RELATED ARTICLESMORE FROM AUTHOR Weekly Psychedelic Policy Briefing, September 21, 2026 Health Canada Authorizes Optimi’s Natural Psilocybin Trial as House Bill Targets Botanical Drug Exclusivity Pα+ Psychedelic Bulletin #232: Q2’26 Psychedelic Lobbying Update; DEA Again Moves to Schedule 5 Tryptamines; Oregon Backpedals Psilocybin Fee Hike
